BM-51
BM-51 is a selective inhibitor of CYP4Z1, with a human IC50 value of 91.7 nM. BM-51 binds to amino acid residues of CYP4Z1, thereby inhibiting its enzymatic activity. BM-51 downregulates the protein expression of stem cell markers (ALDH1A1, SOX2, OCT3/4 and KLF4) in cancer cells, inhibits cancer cell migration and invasion, and exhibits low toxicity to normal cells/tissues. BM-51 suppresses tumor initiation capacity and enhances the chemotherapeutic efficacy of Doxorubicin (HY-15142A). BM-51 can be used in breast cancer-related research.
For research use only. We do not sell to patients.
- CAS No.: 3038211-56-9
- Formula: C17H23N3O
- Molecular Weight:285.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CYP4Z1 91.7 nM (IC50) |
ALDH1A1 |
KLF4 |
In Vitro
BM-51 potently inhibits the enzymatic activity of CYP4Z1 (IC50 = 91.7 nM)[1] by binding to the Arg384, Ser383, Val126 and Ala314 amino acid residues of CYP4Z1 in HEK293T cell lysates.
BM-51 (500 μM; 30 min) directly binds to the Arg384, Ser383, Val126 and Ala314 sites of CYP4Z1 in protein extracts[1].
BM-51 reduces the mammosphere-forming capacity (a tumor-initiating cell-like trait) of 4T1 cells overexpressing wild-type CYP4Z1, but exerts no such effect on cells overexpressing CYP4Z1Arg384, CYP4Z1Ser383, CYP4Z1Val126 or CYP4Z1Ala314[1].
BM-51 reduces the proportion of CD44+/CD24− tumor-initiating cell (TIC) subsets in 4T1 cells overexpressing wild-type CYP4Z1, but exerts no such effect on cells overexpressing CYP4Z1 with mutations at Arg384, Ser383, Val126 or Ala314[1].
BM-51 (0.01-100 μM; 72 h) shows no significant inhibitory effect on cell viability in MCF-7, MDA-MB-231 and 4T1 cells[1].
BM-51 (0.25-10 μM; 24-48 h) exhibits significant inhibitory effects on cell migration in MCF-7 and MDA-MB-231 cells [1].
BM-51 (0.25-10 μM) downregulates the protein expression levels of stem cell markers ALDH1A1, SOX2, OCT3/4 and KLF4 in MCF-7 and MDA-MB-231 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF-7, MDA-MB-231, 4T1 cells
-
Concentration:0.01, 0.1, 1, 10 and 100 μM
-
Incubation Time:72 h
-
Result:Did not significantly inhibit cell viability in MCF-7, MDA-MB-231, and 4T1 cells, with an IC50 > 20 μM
-
Cell Line:MCF-7 and MDA-MB-231 cells
-
Concentration:0.25, 1.0 μM (MDA-MB-231 cells); 2.5, 10 μM(MDA-MB-231 cells)
-
Incubation Time:24 h (MDA-MB-231 cells); 48 h(MDA-MB-231 cells)
-
Result:Wound healing and Transwell invasion assays (with Matrigel coating) demonstrated significant inhibition of cell migration and invasion in MCF-7 and MDA-MB-231 cells.
In Vivo
BM-51 (10 mg/kg; daily; for 14 consecutive days) enhances the chemotherapeutic efficacy of Doxorubicin (HY-15142A) against MCF-7 breast cancer xenografts, inhibits tumor stemness, and exhibits low toxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (female; PyMT-CYP4Z1 and PyMT-MMTV genotypes; spontaneous breast cancer tumorigenesis model)[1]
-
Dosage:10 mg/kg
-
Administration:i.v.; every 3 days; 6 weeks
-
Result:Significantly delayed tumor initiation in PyMT-CYP4Z1 mice.
Reduced tumor size, count, volume, and weight in PyMT-CYP4Z1 mice.
Decreased the number and size of metastatic lung nodules in PyMT-CYP4Z1 mice.
Reduced the number and size of hyperplastic mammary gland lesions at 15 weeks in PyMT-CYP4Z1 mice.
Decreased the proportion of luminal progenitor (CD29^lo CD24^+) cells in PyMT-CYP4Z1 mice.
Increased the proportion of basal (CD29^+ CD24^+) cells in PyMT-CYP4Z1 mice.
Had no effect on mammary gland development in normal wild-type mice.
Modestly reduced common myeloid progenitor (CMP) bone marrow subsets in normal wild-type mice.
Caused no notable changes in other hematopoietic progenitor subsets or peripheral blood cell counts in normal wild-type mice.
Left PyMT mRNA levels in PyMT-CYP4Z1 tumors unchanged.
-
Animal Model:BALB/c nude (male; 6 weeks old; MCF-7 cell subcutaneous xenograft model)[1]
-
Dosage:10 mg/kg
-
Administration:daily; 14 days
-
Result:Did not significantly suppress tumor progression when used alone compared with control.
Enhanced the tumor-suppressive effects of Adriamycin, resulting in reduced tumor weight and volume relative to Adriamycin alone.
Did not alter mouse body weight, indicating low toxicity.
Suppressed the expression of stemness markers in tumors.
Chemical Information
-
CAS No. 3038211-56-9
-
Molecular Weight 285.38
-
Formula C17H23N3O
-
SMILES
O=C(NC(C)CCC)CC1=CC=C(CN2C=NC=C2)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Scratch/Wound-Healing Migration Assay
The scratch/wound-healing migration assay measures collective migration of adherent cells into an experimentally created cell-free gap in a confluent monolayer. The readout is generated by imaging the gap immediately after scratching and at later time points, then quantifying reduction in wound area, wound width, or percentage closure as cells move into the denuded region. Gap closure reflects cell migration but may also include cell proliferation, so interpretation should distinguish migration-focused conditions from proliferation-driven closure when possible, such as by using short assay windows, serum-controlled conditions, cell counting, or proliferation controls reported in published protocols.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Neural Crest/Neuronal Cell Migration Explant Assay
Neural crest (NC) and neuronal cell migration explant assays are in vitro systems in which neural tube-derived tissues are cultured to allow premigratory or newly emigrated neural crest cells to undergo epithelial-to-mesenchymal transition (EMT), migrate away from the explant, and form a measurable radial outgrowth that reflects migratory capacity and environmental responsiveness. These assays typically quantify migration by measuring the expansion of cell outgrowth from neural tube or neural plate border explants over time, often comparing early and later timepoints to derive a migration index such as a radius ratio, which reflects net cell dispersal from the explant core. Neural tube explant cultures preserve key aspects of neural crest behavior, including EMT, migration, and early differentiation, making them suitable for assessing intrinsic migratory ability and extrinsic cue dependence. However, studies emphasize that migratory outgrowth from neural tube explants may include non-n
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Protocol For Protein Expression And Purification
Recombinant protein expression in Escherichia coli followed by purification of a His-tagged soluble protein by immobilized metal affinity chromatography (IMAC), with optional MBP fusion and TEV tag removal when the construct includes these elements. The biological readout is production of the encoded target protein, detected as an inducible band at the expected molecular mass by SDS-PAGE and quantified by total protein assay or chromatographic absorbance; the purification readout is enrichment of the target protein in elution fractions after selective binding of polyhistidine residues to immobilized Ni2+/metal-chelate resin and elution by imidazole-containing buffer. Expression is driven by an inducible bacterial expression system, commonly T7/lac-based, in which IPTG or lactose/auto-induction activates transcription and translation of the cloned gene; lower induction temperature, lower inducer concentration, induction timing, and solubility-enhancing fusion tags can influence the frac
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Chemotaxis Gradient Chamber Assay 1
The chemotaxis gradient chamber assay is based on the principle of observing directional cell migration in response to a stable, linear or quasi-linear concentration gradient of a chemoattractant formed between two fluid reservoirs separated by a narrow observation chamber. Cells placed within the chamber respond to the gradient by polarized movement toward higher chemoattractant concentrations, allowing quantification of chemotactic behavior in real time under microscopy. The classic Zigmond chamber design enables simultaneous visualization of gradient formation and individual cell trajectories, making it suitable for studying leukocyte chemotaxis and other motile cell types in vitro.
-
Under-Agarose Cell Migration Assay
The under-agarose cell migration assay is a classical in vitro chemotaxis method designed to evaluate directed cell movement through a semi-solid agarose matrix toward soluble chemoattractant gradients, enabling visualization and quantification of leukocyte or motile cell migration in a confined 2D-like environment. In this system, cells and chemoattractants are placed in separate wells cut into an agarose gel, allowing diffusion-driven gradient formation that guides directional migration, which is typically assessed by measuring migration distance, cell morphology changes, and accumulation toward the chemoattractant source. This assay has been widely used to study neutrophil and leukocyte chemotaxis as a simple alternative to filter-based migration systems and allows direct microscopic observation of migrating cells under near-physiological confinement conditions.
-
Transwell/Boyden Chamber Migration Assay
The Transwell/Boyden chamber migration assay measures cell movement through a porous membrane separating an upper and lower chamber, usually after a chemoattractant gradient is established by placing cells in the upper chamber and chemoattractant-containing medium in the lower chamber. The readout is generated by quantifying cells that traverse the membrane and appear on the lower membrane surface or in the lower chamber, depending on whether the cell type is adherent or non-adherent. This assay reflects chemotactic or haptotactic migration rather than matrix invasion unless an extracellular-matrix barrier is added to the membrane.
-
3D Collagen/Hydrogel Matrix Migration Assay
The 3D collagen/hydrogel matrix migration assay is based on embedding cells within or on top of a fibrillar collagen type I-rich three-dimensional matrix to model in vivo-like extracellular matrix (ECM) architecture, enabling analysis of cell migration through a physically and biochemically relevant scaffold. In contrast to 2D migration systems, cells in 3D matrices interact with fibrillar collagen networks, requiring coordinated adhesion remodeling and proteolytic or non-proteolytic deformation mechanisms to move through confined spaces, thereby providing a more physiologically relevant readout of invasive and migratory behavior in tissue-like environments. Cell movement in 3D collagen matrices is typically quantified by tracking single-cell trajectories, invasion depth, or matrix penetration over time, reflecting combined effects of cytoskeletal dynamics, cell-ECM adhesion turnover, and ECM remodeling. These systems are widely used to study tumor cell invasion and stromal cell motili
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Cell-Exclusion Zone Migration Assay
The Cell-Exclusion Zone (CEZ) migration assay is an in vitro 2D cell migration method in which a defined cell-free area is created using removable physical barriers such as silicone stoppers, allowing cells to be seeded around the barrier and subsequently migrate into the cleared zone after barrier removal. This approach enables quantification of collective cell migration by monitoring repopulation of the initially cell-free region over time using microscopy-based imaging. Compared with scratch-based wound healing assays, barrier-based exclusion methods are designed to avoid mechanical damage to the extracellular matrix and reduce injury-induced effects on boundary cells, thereby improving interpretability of migration behavior in vitro. The assay readout is typically the progressive reduction in the cell-free area or the number of cells invading the exclusion zone, reflecting coordinated cell motility relevant to physiological processes such as wound healing, epithelial repair, and ca
-
Chemotaxis Gradient Chamber Assay 2
Chemotaxis gradient chamber assays measure directional cell migration in response to a soluble chemical gradient by imaging cells as they move across a defined observation region; the readout is generated from time-lapse cell trajectories, displacement toward the gradient, forward migration index, trajectory plots, rose/polar plots, and statistical tests of non-random directionality. The Dunn chamber is a direct-viewing glass chamber in which cells migrate across a bridge between control and chemoattractant wells, allowing observation of cells in a linear concentration gradient; related direct-viewing formats include the Insall chamber, which supports defined unidirectional gradients and high numerical-aperture microscopy, and the μ-Slide Chemotaxis chamber, which supports long-term live-cell imaging and gradient characterization with fluorescent dye.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)